Luxación anterior articulación esternoclavicular
Common bile duct injury is a severe complication. It is related to increased rates of morbidity and mortality. Early recognition and on-time diagnosis plus multidisciplinary management of this disease led by a hepatobiliary surgeon show fewer complications rate and best postoperative outcomes. However, no guidelines exist about the proper time of reconstruction. This study aims to describe the experience of a specialized Hepato-Pancreatic-Biliary (HPB) group and to analyze the outcomes regarding the time of bile duct injury (BDI) repair. A multicenter retrospective review of a prospective database was conducted. All the patients older than 18 years old that underwent common bile duct reconstruction between January 2014 and December 2021 were included. Analysis and description of preoperative characteristics and postoperative outcomes were performed. A reconstruction time-based group differentiation was made and analyzed. 44 patients underwent common bile duct reconstruction between January 2014 and December 2021. 56.82% of the patients were female. The mean age was 53.27 years ± 20.7 years. The most common injury was type E2 (29.55%). Hepaticojejunostomy was performed in 81.81% (of the patients. Delayed reconstruction (> 72 h) was performed in the majority of the cases (75.00%) due to delays in the referral centers or poor condition. No statistically significant difference regarding complications in early or delayed BDI reconstruction. The mortality rate was 2.7% (n = 1). 2-year follow-up bilioenteric stenosis was observed in 7 patients. Biloma showed a statistical relationship with complex bile duct injuries (p = 0.02). Bile duct injury is a severe and complex postoperative complication that increases morbidity and mortality rates in the short and long term in patients undergoing cholecystectomy. In our study, there were no statistical differences between the timing of bile duct reconstruction and the postoperative outcomes; we identified the presence of biloma as a statistically related factor associated with complex bile duct injury; however, further prospective or studies with an increased sample size are required to prove our results.
BackgroundBicuspid aortic valve is one of the most common congenital heart malformations affecting 2% of the population. There is a gap in the literature regarding the Latin-American population, the aim of this study is to analyze the demographic, clinical characteristics and the surgical outcomes of patients with bicuspid aortic valve (BAV) with a 1,5 and 10 year follow-up in a single center.MethodsWe performed a retrospective review of a prospectively collected database. All patients that underwent aortic-valve related procedures with bicuspid aortic valve finding between 2011-2021 were included. Comparison between groups were performed using paired t-test or Mann Whitney-Wilcoxon when appropriate. Statistically significant value was accepted if < 0.05. Results: 82 patients were included. Male patients constituted 71.95% of the population. Median age was 58 years (IQR 47;65). Type 1 BAV were the most common finding (85.19%). Aortic stenosis was the most common clinical feature in 64.64% of the cases. Coronary artery disease and smoking history are related with decreased left ventricular function with statistically significant value (p 0.02 - 0.03 respectively). Mortality rate was 2.44. Overall survival rate after 1-5 and 10 years was 97.56%, 96.42%, and 80.5% respectively.Conclusions: Patients with associated coronary artery disease and smoking history should be considered high risk patients due to the relationship with decreased left ventricular function even with an asymptomatic course. Further prospective studies are needed to prove our results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.